6/25/2025 Categories: Industries Angelini Industries: in 2024 net income up 30% to € 156 million. Group revenues (+3%) and EBITDA (+17%) also on the rise
1/4/2021 Categories: Pharma Angelini Pharma acquires Arvelle Therapeutics to create a leading European innovator in Central Nervous System (CNS) and Mental Health Disorder treatments
12/22/2020 Categories: Consumer Goods MadreNatura and Angelini Foundation: food adoption kicks off in collaboration with Banco Alimentare Lombardia and Abruzzo
12/1/2020 Sergio Marullo di Condojanni (Angelini Holding) participates in the G20 Business Summit - B20
9/9/2020 Luxottica and Fameccanica start the national production of face masks at PalaLuxottica in Agordo
7/8/2020 Piero Tansella joins Angelini Holding to coordinate and develop the Group Business Consumer unit
Angelini Industries
